Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
Bill Faloon inviting people to join a pay-to-participate clinical trial.
Will test transfusions of young blood.
Potentially live longer and some chronic problems may disappear.
People considering enrolling may have to pay $285,000.
The study was published in the Heliyon journal.
Click on resource name for more details.
Senior Investigator and Co-chair at Harvard Department of Stem Cell and Regenerative Biology
Biotechnology company leading the field of regenerative medicine developing treatments for unconquered injuries and diseases.
Scientific journal providing information on research across life, physical, social, and medical sciences.
